Difference in Central Fatigue During Two Ultra-endurance Practices: Running vs. Cycling

Inclusion criteria

• Specialist in endurance and ultra-endurance. in the 2 disciplines: running and cycling (triathletes, duathletes or trailers achieving at least 30% of their training volume in cycling), and having at least finished one long distance event in the last 2 years,
• Affiliated or beneficiary of a social security scheme.
• Signature of the consent form

Exclusion criteria

• Any subject who has been injured in the 3 months prior to the protocol
• Anyone with chronic joint pathologies (e.g.: repetitive sprains, patellar or ligament problems).
• Any subject with chronic or central neurological pathologies
• Any subject with a contraindication to magnetic stimulation
• Use of neuro-active substances likely to alter cortico-spinal excitability (hypnotics, antiepileptics, psychotropic drugs, muscle relaxants) on the study.
• Contraindication to the application of a magnetic field:

• Heart or respiratory insufficiency.
• Subject with a cardiac pace maker.
• Cardiac valve wear and serious cardiovascular diseases.
• Presence of prosthetic material or ferromagnetic foreign bodies in the head.
• Presence of cochlear implants or ocular prosthetic material.
• History of neurosurgical interventions.
• Neurological diseases that may affect brain structures and cognitive abilities (e.g., intracranial tumour, multiple sclerosis, history of stroke or traumatic brain injury).
• History of comitiality, contralateral knee disease or musculoskeletal disease.
• Any subject participating at the same time in another interventional experiment requiring physical exercise.
• Any subject who has taken corticosteroids within 3 months (inhalation, infiltration or history of prolonged corticosteroid therapy).
• Any subject under guardianship or curatorship